11/29 to 12/02
BRAZILIAN NATIONAL PROGRAM OF GENOMIC AND PRECISION HEALTH
Institutionalized through Decree nº 1.949/GM/MS, on August 4th of 2020, Genomas Brasil is a science, technology and innovation program, coordinated by the Department of Science and Technology, of the Secretariat of Science, Technology, Innovation and Strategic Input in Health, from the Ministry of Health (Decit/SCTIE/MS), that aims to overcome structural limitations found in the country to allow the implementation of precision and personalized medicine in the Unified Health Service (SUS).
The specific objectives of Genomas Brasil are:
strengthen the field of science and technology in precision and personalized medicine in the country;
establish a pilot research project to assess the feasibility of implementing a line of care based on genomics in the SUS;
stimulate and strengthen the development of the national industry in the area of precision and personalized medicine.
CONFERENCE TOPICS: Applications of genomic medicine in the SUS; Genomic information; Ethical, legal and social aspects of genomic data; Population genomics: underrepresented populations; Accelerating access to precision medicine in global health; The role of the genome in the pharmacological response; Precision Medicine and Advanced Therapy Products.
JOIN OVER A THOUSAND GLOBAL PARTICIPANTS
Faced with the growing expansion of scientific, technological and innovation advances in health, the world is increasingly discussing the adoption of precision health to improve the quality of life of the population and the rational use of public investment in health.
The 2nd GENOMAS BRASIL INTERNATIONAL SUMMIT will address the theme “Implementing Genomics and Precision Health: Advances and Challenges”.
GET READY FOR THE 2nd GENOMAS BRASIL INTERNATIONAL SUMMIT
The 2nd Genomas Brasil International Summit will bring together speakers from management and health systems, as well as national and international scientific communities who have faced the challenge of implementing genomics and precision health as priority issues. The summit will discuss the main challenges and advances in this field on the world stage, structured to bring benefits and quality of life to the population.
COME JOIN THE DISCUSSION ABOUT RECENT ADVANCES IN GENOMICS AND PRECISION HEALTH. BE PART OF THIS STORY!
Welcome! Opening Ceremony
9:15 AM – 10:00 AM
Speaker 1 (10 min) - Marcelo Antonio Cartaxo Queiroga Lopes (Brazilian Minister of Health)
Speaker 2 (10 min) - Sandra de Castro Barros (Secretary of Science, Technology, Innovation and Health Strategic Products – SCTIE; Ministry of Health – MS)
Speaker 3 (10 min) - Alessandra De Sá Earp Siqueira (Departament of Science and Technology – DECIT/SCTIE/MS)
Speaker 4 (10 min) - Priscilla Azevedo Souza (General Coordination of strategic Actions in Clinical Research – CGPClin/DECIT/SCTIE/MS)
Keynote - Genomas Brasil: National Program of Genomics and Precision Medicine
10:00 AM - 10:30 AM
Speaker- Alessandra De Sá Earp Siqueira (Department of Science and Technology – DECIT/SCTIE/MS)
Chair- Adriana Bastos Carvalho (Federal University of Rio de Janeiro – UFRJ)
10:30 AM - 10:45 AM - Questions & Answers
10:45 AM - 11:00 AM - Break
Panel - Use of genomics in a clinical environment: Pilot studies from GenBR
11:00 AM - 12:00 PM
Speaker 1 (20 min) - Adriana Bastos Carvalho (Federal University of Rio de Janeiro – UFRJ) – National Network of Cardiovascular Genomics (RENOMICA): DNA sequencing for SUS patients with hereditary cardiovascular diseases
Speaker 2 (20 min) - João Bosco Oliveira (Albert Einstein Hospital) – Rare Genomes Project: use of the WGS for the diagnosis of rare diseases within the SUS
Speaker 3 (20 min) - Marina Candido Visontai Cormedi (University of São Paulo – USP) - Precision prevention and treatment biomarkers: using genomics in cancer care
Chair- Lygia da Veiga Pereira Carramaschi (University of São Paulo – USP)
12:00 PM - 12:30 PM - Questions & Answers
11/29 to 12/02
TOPICS OF CONFERENCE
Applications of genomic medicine in the SUS
Ethical, legal and social aspects of genomic data
Population genomics: underrepresented populations
Accelerating access to precision medicine in global health
The role of the genome in the pharmacological response
Precision Medicine and Advanced Therapy Products